These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17006835)

  • 21. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
    Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
    Czarniecka A; Włoch J; Lange D
    Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant?].
    Walgenbach S; Junginger T
    Zentralbl Chir; 2002 May; 127(5):435-8. PubMed ID: 12058304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical course and treatment of patients with differentiated thyroid carcinoma diagnosed during the year 1995].
    Czarniecka A; Włoch J; Jarzab M; Krajewska J; Kukulska A; Roskosz J; Puch Z; Wróbel A; Wollak M; Turska M; Stojcev Z; Maka B
    Endokrynol Pol; 2005; 56(5):758-65. PubMed ID: 16817141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversies in the surgical management of differentiated thyroid carcinoma.
    Noguchi M; Katev N; Miyazaki I
    Int Surg; 1996; 81(2):163-7. PubMed ID: 8912084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
    Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
    Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
    Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
    Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases.
    Bal CS; Garg A; Chopra S; Ballal S; Soundararajan R
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):745-51. PubMed ID: 25210762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reoperation in differentiated carcinoma of the thyroid gland].
    Maffei Faccioli A; Pelizzo MR; Toniato A; Bernante P; Piotto A
    Chir Ital; 1994; 46(4):59-60. PubMed ID: 7882446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution.
    Sciuto R; Romano L; Rea S; Marandino F; Sperduti I; Maini CL
    Ann Oncol; 2009 Oct; 20(10):1728-35. PubMed ID: 19773250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
    Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
    Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients.
    Kuo EJ; Roman SA; Sosa JA
    Surgery; 2013 Dec; 154(6):1246-53; discussion 1253-4. PubMed ID: 23993409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
    Pozzetto B; Roseano M; Dellach C; Leggeri A
    Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.